Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia

scientific article published on 26 April 2018

Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SCHRES.2018.04.030
P932PMC publication ID6203675
P698PubMed publication ID29705007

P50authorFelipe V. GomesQ47705373
P2093author name stringAnthony A Grace
David W Volk
Jessica R Edelson
P2860cites workEndocannabinoid signaling controls pyramidal cell specification and long-range axon patterningQ24650912
Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.Q24681363
Translating the MAM model of psychosis to humansQ26860217
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron typesQ28262858
Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?Q28279719
Cortical inhibitory neurons and schizophreniaQ29547683
The adolescent brain and age-related behavioral manifestationsQ29618654
A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophreniaQ30465716
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophreniaQ30494823
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.Q30497212
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatumQ31817073
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophreniaQ33932087
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapsesQ33940688
Schizophrenia as a disorder of developmentally reduced synaptic connectivityQ33965926
Schizophrenia: an integrated sociodevelopmental-cognitive modelQ34023115
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.Q34214883
Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptorQ34245130
Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areasQ34300051
Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortexQ34350080
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.Q34514461
Neurodevelopment, GABA system dysfunction, and schizophreniaQ34675943
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunctionQ35044627
Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophreniaQ35612878
CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental RegulationQ35820005
Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophreniaQ35835597
Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and SchizophreniaQ35990574
Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disordersQ36499391
Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterationsQ36618870
Rethinking schizophrenia in the context of normal neurodevelopmentQ36844622
A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophreniaQ37369353
Synapse formation and regression in the cortex during adolescence and in schizophreniaQ37394104
Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in MiceQ37609566
Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopmentQ37740262
Corticostriatal circuitryQ38805959
Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM modelQ38846609
CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortexQ38959085
Hardwiring the brain: endocannabinoids shape neuronal connectivityQ39798626
Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.Q42520647
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatmentQ43299005
Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex.Q44741537
Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophreniaQ47365827
Gamma oscillations correlate with working memory load in humansQ48146164
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia.Q48481384
The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.Q49551829
Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study.Q51976878
Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.Q52030475
SchizophreniaQ56959104
P921main subjectschizophreniaQ41112
P304page(s)254-260
P577publication date2018-04-26
P1433published inSchizophrenia ResearchQ7431607
P1476titleAltered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia
P478volume201

Reverse relations

cites work (P2860)
Q94569525Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Q92097819Physiology of the Endocannabinoid System During Development

Search more.